Skip to content

Clinical trials

Phase 2 Waldenstrom Macroglobulinemia trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Waldenstrom Macroglobulinemia Phase: Phase 2 Status: Unknown status Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20111
20161
20171
20181
20191
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Auxilio Mutuo Cancer Center1
Kosin University Gospel Hospital1
Medical College of Wisconsin1
National Taiwan University Hospital1
Polish Myeloma Consortium1
Seoul National University Hospital1
Shanghai Changzheng Hospital1
University College, London1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Waldenstrom Macroglobulinemia8
Lymphoma, B-Cell, Marginal Zone4
Lymphoma, Follicular4
Leukemia, Lymphocytic, Chronic, B-Cell3
Lymphoma3
Lymphoma, Non-Hodgkin3
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Burkitt Lymphoma2
Hodgkin Disease2
Leukemia2

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.